CXCR4

C-X-C chemokine receptor type 4 (CXCR4, fusin, CD184) is a homeostatic Gαi-coupled receptor with a single ligand, CXCL12 (SDF-1), a pairing conserved from fish to mammals and essential for life: knockout of either gene is perinatally lethal with defects in hematopoiesis, cardiogenesis, vascular and nervous system development. CXCR4 is expressed on hematopoietic stem cells, naive and memory T cells, B cells, monocytes, neutrophils, endothelial and neural progenitors. Its functions span stem-cell retention in the CXCL12-rich bone marrow niche (the therapeutic target of plerixafor for stem-cell mobilization), lymphocyte trafficking and tissue development. CXCR4 is famously the principal co-receptor for X4-tropic HIV-1 strains. In cancer, CXCR4 is the most frequently upregulated chemokine receptor across tumor types, driving organ-specific metastasis toward CXCL12-rich organs (lung, liver, bone marrow, brain), promoting tumor growth, angiogenesis and survival under therapy, and informing metastasis risk stratification; CXCR4 inhibitors are in clinical trials for warts, hypogammaglobulinemia and advanced cancers.